NEULANDLAB Intraday Analysis...

NEULANDLAB Share Price

Open 1264.00 Change Price %
High 1281.00 1 Day 0.75 0.06
Low 1225.00 1 Week 122.80 10.89
Close 1250.80 1 Month 342.65 37.73
Volume 15025 1 Year 540.20 76.02
52 Week High 1329.55
52 Week Low 672.00
NEULANDLAB Important Levels
Resistance 2 1302.71
Resistance 1 1281.32
Pivot 1252.27
Support 1 1220.28
Support 2 1198.89
NSE INDIA Most Active Stocks
SREINFRA 86.00 -3.32%
JPASSOCIAT 13.40 0.37%
SUZLON 18.90 -0.53%
IDEA 90.90 -0.76%
SIGNET 16.45 0.00%
BANKBARODA 169.05 4.22%
UNITECH 5.75 0.88%
SBIN 276.50 2.98%
PNB 141.50 4.16%
ICICIBANK 274.75 2.92%
More..
NSE INDIA Top Gainers Stocks
RASOYPR 0.20 33.33%
ATNINTER 0.25 25.00%
AUSTRAL 0.30 20.00%
FCSSOFT 0.30 20.00%
STARPAPER 171.05 19.99%
CIMMCO 89.15 19.99%
BALKRISHNA 84.20 19.86%
GTNTEX 17.35 19.66%
LGBFORGE 7.35 18.55%
SMPL 2.25 18.42%
More..
NSE INDIA Top Losers Stocks
POLYMED 246.95 -54.63%
VKSPL 0.05 -50.00%
FARMAXIND 0.05 -50.00%
NAKODA 0.35 -12.50%
VIPULLTD 60.10 -12.20%
REFEX 23.20 -9.90%
MVL 0.50 -9.09%
MVL 0.50 -9.09%
NLCINDIA 109.80 -8.84%
ZENITHBIR 0.55 -8.33%
More..

Neuland Laboratories Limited (NSE: NEULANDLAB)

NEULANDLAB Technical Analysis 5
As on 24th Mar 2017 NEULANDLAB Share Price closed @ 1250.80 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 946.57 & Strong Buy for SHORT-TERM with Stoploss of 1021.87 we also expect STOCK to react on Following IMPORTANT LEVELS.
NEULANDLAB Target for March
1st Target up-side 965.21
2nd Target up-side 1001.6
3rd Target up-side 1037.98
1st Target down-side 861.39
2nd Target down-side 825
3rd Target down-side 788.62
NEULANDLAB Synopsis Technicals View
50 Day EMA Close is Above EMA 50 (Short Term)
Bullish
100 Day EMA Close is Above EMA 100 (Mid Term) Bullish
200 Day EMA Close is Above EMA 200 (Long Term) Bullish
MACD (12 26 9) MACD Line is Grater Then SIGNAL Line Bullish
RSI (14) RSI is Above 70 Over Bought
MFI (14) MFI is 61.02 Sideways
CCI (20) CCI is Above 100 Over Bought
WILLIAM %R (14) William %R is -33.73 Sideways
ADX (14) ADX is Above 20 & +DI is Above -DI Up Trend
PSAR Stoploss For Long Buy 1093.55
10 Day Avg Volume Traded -67.64 % Less then 10 Day Average Volume
NEULANDLAB Other Details
Segment EQ
Market Capital 0.00
Sector Pharmaceuticals
Industry
Offical website
NEULANDLAB Address
NEULANDLAB
N/A
NEULANDLAB Latest News
Neuland Lab breaches 20% lower circuit   Indiainfoline   - 02nd Feb 15
Neuland Labs Reports Third Quarter Fiscal Year 2015 Financial Results   PR Newswire (press release)   - 30th Jan 15
Neuland Labs Reports Another Successful FDA Audit And Wins 2015 CMO ...   PR Newswire (press release)   - 26th Jan 15
Neuland Laboratories Ltd to consider Q3 results on Jan 30, 2015   Equity Bulls   - 10th Jan 15
Neuland Labs Q2 net up 50%   Business Standard   - 30th Oct 14
Neuland Laboratories Ltd Rights Issue to open on September 29, 2014   Equity Bulls   - 25th Sep 14
Neuland Laboratories opens facility for API Corporation   Hindu Business Line   - 09th Apr 14
Buy Neuland Laboratories; target Rs 306: Firstcall Research   Moneycontrol.com   - 13th Mar 14
Neuland Labs to focus on higher margin products   Hindu Business Line   - 27th Jun 13
Neuland Lab - Allotment of Equity Shares   Moneycontrol.com   - 15th May 11
Interactive Technical Analysis Chart Neuland Laboratories Limited ( NEULANDLAB NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Neuland Laboratories Limited
NEULANDLAB Business Profile
Neuland Lab is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 213.12 crore.The company has reported a standalone sales of Rs 105.10 crore and a Net Profit of Rs 3.44 crore for the quarter ended Sep 2013.The company management includes Davuluri Rama Mohan Rao - Chairman & Managing Director, D Sucheth Rao - Wholetime Director & CEO, D Saharsh Rao - WholeTime Dire. & President, G V K Rama Rao - Non Executive Director, Humayun Dhanrajgir - Independent Director, Shashi Bhushan Budhiraja - Independent Director, Parampally Vasudeva Maiya - Independent Director, William Gordon Mitchell - Independent Director, Christopher M Cimarusti - Non Executive Director, Nadeem Panjetan - Nominee Director. It is listed on the BSE with a BSE Code of 524558 and the NSE with an NSE Code of NEULANDLAB.Its Registered office is at 'Sanali Info park, 'A' Block,' Ground floor, 8-2-120/113,,Road No.2, Banjara Hills Hyderabad,Andhra Pradesh - 500034.Their Registrars are Karvy Computershare Private Ltd.